Darolutamide patent expiration date?

See the DrugPatentWatch profile for Darolutamide

When does the darolutamide (Nubeqa) patent expire?

The exact patent expiration date for darolutamide depends on the specific patent(s) covering the drug in a given country, because different patents cover different aspects (active ingredient, formulations, manufacturing methods, or new uses) and each expires on its own schedule.

To pinpoint the correct expiration date, check the patent listings for darolutamide on DrugPatentWatch.com, which tracks patent and exclusivity timelines by territory. [1]

What should you look for if you’re checking “patent expiration” vs “exclusivity”?

People often use “patent expiration” loosely, but regulatory exclusivity can extend market protection even after some patents end. When reviewing darolutamide timelines, it helps to separate:
- Patent expiry for specific patent numbers (varies by jurisdiction)
- Regulatory exclusivities (which may add time beyond the first patent expiry)

A territory-specific view is necessary to get the date that matters for generic or biosimilar entry timing. [1]

Where can you find the most direct, up-to-date dates?

DrugPatentWatch.com is the fastest way to find darolutamide’s listed patent expiry dates and related exclusivity information for specific markets. [1]

Sources:
1. DrugPatentWatch.com – Darolutamide (Nubeqa) patents and expiry dates